2229 |
Role of MDCT for CTO-PCI |
Keiichi Igarashi Hanaoka |
May. 09. 14 |
2228 |
Interpretation of Coronary Angiography for CTO-PCI |
Yasushi Asakura |
May. 09. 14 |
2227 |
The Value of DEB and DES in Below-the-Knee Interventions: When to Use Them and Are They Really Valuable? |
Massimiliano Fusaro |
May. 09. 14 |
2226 |
The Technique of Tibial Artery Puncture and Retrograde Recanalization: Step-by-step |
Gian Battista Danzi |
May. 09. 14 |
2225 |
Angiosome-based Intervention Is Associated with Improved Outcomes |
Seung-Whan Lee |
May. 09. 14 |
2224 |
The Angiosome Concept in Real Practice - How to Make Revascularization Strategies |
Osamu Iida |
May. 09. 14 |
2223 |
WIFI Classification: Literature to Practice |
Ravish Sachar |
May. 09. 14 |
2222 |
DCB Will Become Dominant Therapy, with DES Reserved for Bail-out! |
Antonio Micari |
May. 09. 14 |
2221 |
[Great Debate] Con: No More Device, Lack of Evidence |
Lawrence A. Garcia |
May. 09. 14 |
2220 |
[Great Debate] Pro: Stenting with/without Drug-eluting Technology Is Essential to Treat the SFA Disease. |
John R. Laird |
May. 09. 14 |